Looking to the future with COVID-19 immunotherapy
We are preparing for “with COVID” as a way to recover from the prolonged COVID-19 pandemic. In the meantime, a joint cooperative "IVRA" was established to prepare measures for the efficient treatment of COVID-19, and it is drawing attention by presenting a new medical paradigm through "immune treatment." I met and talked with Yoo Seung-mo, director of Yesan Myongji Hospital, who serves as the chairman of the IVRA and leads patient-centered medical care.
Q. Medieus Queen: Hello. It's an honor to meet the renowned doctor, a pioneer in Korean manual therapy, who teaches doctors. Please briefly introduce yourself and Yesan Myeongji Hospital.
A. Yoo Seung-mo, director of Yesan Myeongji Hospital (hereinafter referred to as Yoo Seung-mo): Hello, I'm Yoo Seung-mo, director of Yesan Myeongji Hospital. When I was young, my father collapsed from a cerebral hemorrhage. By seeing him suffer from a state that is no longer getting better even with his family's efforts, I dreamed of becoming a doctor who completely cured even one cerebral hemorrhage patient like my father. After graduating from medical school, as I thought I needed to know my shortcomings and learn a lot to achieve my dreams, I studied everything helpful from video and photo editing programs in addition to a non-surgical treatment like chiropractic. As a result, I have created the Doctor Ubiomechanic Research Association and the Korean Balance Medical Society, where I study with teachers interested in non-surgical pain treatment. Until now, I have been teaching teachers at the office of the organization in Seoul almost every Saturday.
In order to legalize the manual (correctional) treatment which was outside the system, Prof. Yoon of Yeonsei University, Mr. Yoo, former chairman of medical association, Mr. Park former chairman of a medical newspaper, and I worked together to persuade the Ministry of Health and Welfare to put the treatment within the institutional sphere and as a result, it has established itself as a non-payment item that is covered by loss insurance, which opened a big horizon in the medical community. Professor Yoon Bang-bu and Director Shim Je-sung, who is an advisor to our society, formed the Korean Medical Association in 1997 to teach doctors manual therapy at Yonsei University's auditorium in Sinchon. In 2006, we opened a Complementary Medical Center at Yeoido St. Mary Hospital and started treatment with the determination that manual (calibration) treatment is also helpful to patients in tertiary hospitals.
Currently, I am working little by little for patients and the medical community, and serving as vice president of the Korean Council for Opening Hospital which has 40,000 members. Recently I have started work to contribute to the end of COVID-19 by forming the International Virus Research Alliance (IVRA).
Our Yesan Myongji Hospital was opened in February 2007 by mainly five professionals including a surgeon, neurosurgeon, and orthopedic surgeon who learned about non-surgical pain treatment from me in Seoul at the time, and a physician who worked at Yeouido St. Mary's Hospital with me. In the first two years, there was an unfavorable perception of hospitals from the community, but as a result of constant efforts, it has now grown into a hospital trusted by residents. Our hospital is a small and medium-sized hospital that operates spinal clinics, internal medicine, neurosurgery, orthopedics, surgery, anesthesiology, emergency rooms, special checkups, and general checkups.
Q. You took the lead in introducing Korean manual therapy and compiled manual therapy textbooks. What are the differences from conventional manual therapy and what are the benefits of applying Korean manual therapy to domestic patients?
A. Yoo Seung-mo: When people advise others, they often say, "Don't just look at the trees, look at the whole forest." Balance is the harmony of mental, chemical, and physical balance. If the existing manual therapy is in the form of looking at trees, you can understand that the manual therapy I created is a treatment that looks at the forest. In particular, my manual therapy allows customized treatment by analyzing the human body in three dimensions. A Full Spine Technique that I made has a great advantage. First, it's easy to learn because it's based on the theory of axes. Second, it's easy to apply to patients. Third, it works better than other manual treatments and works in a short time.
In the United States, there are more than 600 cases of neck manual therapy per year, while Korean manual therapy has not had a single accident from neck correction in more than 20 years. In addition, doctors were highly trusted in the past, but now they are not. As doctors perform manual therapy themselves when treating a patient using my technique, patients can feel the sincerity and reliability of the doctors.
Q. Medieus Queen: You are also the chairman of the International Virus Research Alliance (IVRA), a joint cooperative for the treatment of COVID-19. What kind of activities does IVRA have?
A. Yoo Seung-mo: It was a pity to see that the life pattern of people all over the world including our people changed and became more devastated than in the past due to COVID-19. At that time, after reviewing various papers that the virus was vulnerable to heat, I was confident that thermal treatment would be effective in treating the coronavirus. So, I started to treat 20 COVID-19 patients in Seosan Medical Center. The equipment used for this treatment is not KFDA-approved equipment for virus treatment, but it is European CE-certified or Halal-certified equipment that has been certified for stability and effectiveness as cancer treatment equipment. I conducted the treatment based on my experience using this equipment to treat COVID-19-positive patients in Daegu, and I got a surprising result. Professor Jang Hong-seok's team at Seoul St. Mary's Hospital signed an MOU with Seosan Medical Center and treated two Filipino men believed to be infected by a mutant virus. They recovered from the symptoms after three times of treatments and showed positive results in blood tests. Based on the above results, I desperately felt the need for organizations like IVRA and formed IVRA with various countries that agree with me. IVRA plans to present treatments for asymptomatic and mild COVID-19 patients and create a fund to support the development of effective treatments. It will also take the lead in relief efforts to end COVID-19 around the world.
Q. Medieus Queen: I heard that you announced the possibility of immunotherapy for COVID-19 patients through the high-frequency thermal treatment device "Remission 1℃" at a recent conference held by IVRA. I wonder what kind of principles were used to obtain the therapeutic effect.
A. Yoo Seung-mo: The equipment called 'Remission 1℃' is a high-frequency thermal treatment equipment that can raise the temperature when applied to the human body. Since viruses are vulnerable to heat, we are applying this principle to discover treatments and researching treatments that prevent them from becoming serious along with the treatment of COVID-19 asymptomatic and mild patients. As a result of this trial, we are more convinced that it can be an alternative to the new coronavirus treatment. For reference, high-frequency thermal therapy is classified as a type of cancer treatment by the National Institutes of Health in the United States and is an auxiliary treatment to increase the efficacy of radiation or anticancer drugs and an immune treatment to increase immunity.
Q, Medieus Queen: You also talked about research using electronic drugs for virus research. What future are you looking at with electronic drugs?
A. Yoo Seung-mo: Electronic medicine, called "Electrochemical" in English, is a combination of “Electronic” and “Pharmaceutical”, which refers to a medical device that stimulates brain or nerve function using energy such as electric current or magnetic field. Usually, medicines that are easily accessible when a disease occurs are synthetic drugs, which have great side effects as well as effects. However, as electronic drugs have minimal side effects, they will grow into a field that can replace drugs in the future. Developed countries have long been trying to dominate the e-drug market and make it a future food source. Electronic drugs are included in the top 10 promising technologies announced at the World Economic Forum (WEF) in 2018. It is considered a way to drastically reduce medical costs in unpredictable situations such as aging and COVID-19 pandemic. Neuralink, invested by Tesla CEO Elon Musk in 2016 with $100 million (KRW 109.2 billion), is also a notable electronic drug company and is currently studying BMI (brain-computer interface). This company has obtained approval for an innovation device test from the U.S. Food and Drug Administration (FDA). In my country, someone has to do this job and Red & Blue, the company I founded is doing the task. It has difficulty now due to little investment and interest, but it is an important area in securing our future food.
Q. Medieus Queen: Finally, if you have any personal goals, please tell me.
A. Yoo Seung-mo: While the paradigm is shifting from supplier-centered medical care in the past to patient-centered medical care, most of the doctors I have met seem to be buried in the past and are complacent. As long as my health is allowed, I want to contribute to making a patient-centered medical group by continuously eliminating doctors' prejudices and broadening their horizons. Also, I want to establish Yoo Seung Mo medical research institute in Korea that can actually help patients. I hope that Korea will grow into a practically advanced medical country by utilizing my medical infrastructure. There are still many shortcomings, but I will do my best to create a world that I hope and expect.
A. Yoo Seung-mo, director of Yesan Myeongji Hospital (hereinafter referred to as Yoo Seung-mo): Hello, I'm Yoo Seung-mo, director of Yesan Myeongji Hospital. When I was young, my father collapsed from a cerebral hemorrhage. By seeing him suffer from a state that is no longer getting better even with his family's efforts, I dreamed of becoming a doctor who completely cured even one cerebral hemorrhage patient like my father. After graduating from medical school, as I thought I needed to know my shortcomings and learn a lot to achieve my dreams, I studied everything helpful from video and photo editing programs in addition to a non-surgical treatment like chiropractic. As a result, I have created the Doctor Ubiomechanic Research Association and the Korean Balance Medical Society, where I study with teachers interested in non-surgical pain treatment. Until now, I have been teaching teachers at the office of the organization in Seoul almost every Saturday.
In order to legalize the manual (correctional) treatment which was outside the system, Prof. Yoon of Yeonsei University, Mr. Yoo, former chairman of medical association, Mr. Park former chairman of a medical newspaper, and I worked together to persuade the Ministry of Health and Welfare to put the treatment within the institutional sphere and as a result, it has established itself as a non-payment item that is covered by loss insurance, which opened a big horizon in the medical community. Professor Yoon Bang-bu and Director Shim Je-sung, who is an advisor to our society, formed the Korean Medical Association in 1997 to teach doctors manual therapy at Yonsei University's auditorium in Sinchon. In 2006, we opened a Complementary Medical Center at Yeoido St. Mary Hospital and started treatment with the determination that manual (calibration) treatment is also helpful to patients in tertiary hospitals.
Currently, I am working little by little for patients and the medical community, and serving as vice president of the Korean Council for Opening Hospital which has 40,000 members. Recently I have started work to contribute to the end of COVID-19 by forming the International Virus Research Alliance (IVRA).
Our Yesan Myongji Hospital was opened in February 2007 by mainly five professionals including a surgeon, neurosurgeon, and orthopedic surgeon who learned about non-surgical pain treatment from me in Seoul at the time, and a physician who worked at Yeouido St. Mary's Hospital with me. In the first two years, there was an unfavorable perception of hospitals from the community, but as a result of constant efforts, it has now grown into a hospital trusted by residents. Our hospital is a small and medium-sized hospital that operates spinal clinics, internal medicine, neurosurgery, orthopedics, surgery, anesthesiology, emergency rooms, special checkups, and general checkups.
Q. You took the lead in introducing Korean manual therapy and compiled manual therapy textbooks. What are the differences from conventional manual therapy and what are the benefits of applying Korean manual therapy to domestic patients?
A. Yoo Seung-mo: When people advise others, they often say, "Don't just look at the trees, look at the whole forest." Balance is the harmony of mental, chemical, and physical balance. If the existing manual therapy is in the form of looking at trees, you can understand that the manual therapy I created is a treatment that looks at the forest. In particular, my manual therapy allows customized treatment by analyzing the human body in three dimensions. A Full Spine Technique that I made has a great advantage. First, it's easy to learn because it's based on the theory of axes. Second, it's easy to apply to patients. Third, it works better than other manual treatments and works in a short time.
In the United States, there are more than 600 cases of neck manual therapy per year, while Korean manual therapy has not had a single accident from neck correction in more than 20 years. In addition, doctors were highly trusted in the past, but now they are not. As doctors perform manual therapy themselves when treating a patient using my technique, patients can feel the sincerity and reliability of the doctors.
Q. Medieus Queen: You are also the chairman of the International Virus Research Alliance (IVRA), a joint cooperative for the treatment of COVID-19. What kind of activities does IVRA have?
A. Yoo Seung-mo: It was a pity to see that the life pattern of people all over the world including our people changed and became more devastated than in the past due to COVID-19. At that time, after reviewing various papers that the virus was vulnerable to heat, I was confident that thermal treatment would be effective in treating the coronavirus. So, I started to treat 20 COVID-19 patients in Seosan Medical Center. The equipment used for this treatment is not KFDA-approved equipment for virus treatment, but it is European CE-certified or Halal-certified equipment that has been certified for stability and effectiveness as cancer treatment equipment. I conducted the treatment based on my experience using this equipment to treat COVID-19-positive patients in Daegu, and I got a surprising result. Professor Jang Hong-seok's team at Seoul St. Mary's Hospital signed an MOU with Seosan Medical Center and treated two Filipino men believed to be infected by a mutant virus. They recovered from the symptoms after three times of treatments and showed positive results in blood tests. Based on the above results, I desperately felt the need for organizations like IVRA and formed IVRA with various countries that agree with me. IVRA plans to present treatments for asymptomatic and mild COVID-19 patients and create a fund to support the development of effective treatments. It will also take the lead in relief efforts to end COVID-19 around the world.
Q. Medieus Queen: I heard that you announced the possibility of immunotherapy for COVID-19 patients through the high-frequency thermal treatment device "Remission 1℃" at a recent conference held by IVRA. I wonder what kind of principles were used to obtain the therapeutic effect.
A. Yoo Seung-mo: The equipment called 'Remission 1℃' is a high-frequency thermal treatment equipment that can raise the temperature when applied to the human body. Since viruses are vulnerable to heat, we are applying this principle to discover treatments and researching treatments that prevent them from becoming serious along with the treatment of COVID-19 asymptomatic and mild patients. As a result of this trial, we are more convinced that it can be an alternative to the new coronavirus treatment. For reference, high-frequency thermal therapy is classified as a type of cancer treatment by the National Institutes of Health in the United States and is an auxiliary treatment to increase the efficacy of radiation or anticancer drugs and an immune treatment to increase immunity.
Q, Medieus Queen: You also talked about research using electronic drugs for virus research. What future are you looking at with electronic drugs?
A. Yoo Seung-mo: Electronic medicine, called "Electrochemical" in English, is a combination of “Electronic” and “Pharmaceutical”, which refers to a medical device that stimulates brain or nerve function using energy such as electric current or magnetic field. Usually, medicines that are easily accessible when a disease occurs are synthetic drugs, which have great side effects as well as effects. However, as electronic drugs have minimal side effects, they will grow into a field that can replace drugs in the future. Developed countries have long been trying to dominate the e-drug market and make it a future food source. Electronic drugs are included in the top 10 promising technologies announced at the World Economic Forum (WEF) in 2018. It is considered a way to drastically reduce medical costs in unpredictable situations such as aging and COVID-19 pandemic. Neuralink, invested by Tesla CEO Elon Musk in 2016 with $100 million (KRW 109.2 billion), is also a notable electronic drug company and is currently studying BMI (brain-computer interface). This company has obtained approval for an innovation device test from the U.S. Food and Drug Administration (FDA). In my country, someone has to do this job and Red & Blue, the company I founded is doing the task. It has difficulty now due to little investment and interest, but it is an important area in securing our future food.
Q. Medieus Queen: Finally, if you have any personal goals, please tell me.
A. Yoo Seung-mo: While the paradigm is shifting from supplier-centered medical care in the past to patient-centered medical care, most of the doctors I have met seem to be buried in the past and are complacent. As long as my health is allowed, I want to contribute to making a patient-centered medical group by continuously eliminating doctors' prejudices and broadening their horizons. Also, I want to establish Yoo Seung Mo medical research institute in Korea that can actually help patients. I hope that Korea will grow into a practically advanced medical country by utilizing my medical infrastructure. There are still many shortcomings, but I will do my best to create a world that I hope and expect.
#MEDIEUS #Interview #Family MedicineName #BudgetMyungjiHospital #YooSeungmo #KoreanTypeDuctiveTreatment #InternationalVirus Research Cooperation Group #HighFrequencyThermalTreatment #ImmuneTreatment #ElectronicMedicine #KoreaRenownedDoctor #RenownedDoctorinterview #RenownedDoctorSearch #Interview #MDUS
 |
CEO 박보현
메디컬 커머셜 플랫폼, 메디우스 (주)비앤에이치코리아 대표이사
국내최고 디지털마케팅 전문가
[월간 CEO&] 의료전문 컬럼니스트
인터뷰 문의:sales@bnhkorea.co.kr
|